Articles Vol. 67 No. CĐ5-NCKH 04/05/2026

FACTORS ASSOCIATED WITH DYSLIPIDEMIA AMONG PEOPLE WITH PREDIABETES AT THAI BINH UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL

Bui Thi Minh Phuong1,2, Pham Minh Duc1,2, Dang Thuy Van1,2
1 Thai Binh University of Medicine and Pharmacy
2 Trường Đại học Y dược Thái Bình
DOI: 10.52163/yhc.v67iCD5.5000
23 Views
13 Downloads
Keywords
Prediabetes; Dyslipidemia; Risk factors; Blood lipids; Cross-sectional study
Abstract

Objectives: To describe the prevalence of dyslipidemia and to investigate anthropometric measures, blood pressure, and lifestyle factors that may be associated with prediabetes.

Subjects and Methods: A cross-sectional descriptive study was conducted on 104 individuals with prediabetes (December 2024–February 2025). Data were collected on anthropometric measurements, blood pressure, fasting blood glucose, smoking status, exposure to secondhand smoke, and physical activity. Associations were analyzed using comparisons between two groups and logistic regression.

Results: The prevalence of dyslipidemia was 66.3%. No statistically significant differences were found by sex, BMI, waist circumference, fasting glucose, smoking, secondhand smoke exposure, or physical activity level (p>0.05). Diastolic blood pressure in the dyslipidemia group was lower than in the non-dyslipidemia group (p<0.05). Multivariable logistic regression did not identify any independent associated factors (p>0.05).

Conclusion: Dyslipidemia is highly prevalent among individuals with prediabetes; early screening should be strengthened, and further studies with larger sample sizes are needed.

References
[1]
Committee ADAPP. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care 1 January 2022. 2022;45((Supplement_1)) Google Scholar
[2]
Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet (London, England). Jun 16 2012;379(9833):2279-90. doi:10.1016/s0140-6736(12)60283-9 Google Scholar
[3]
Grundy SM. Metabolic syndrome update. Trends in cardiovascular medicine. May 2016;26(4):364-73. doi:10.1016/j.tcm.2015.10.004 Google Scholar
[4]
Gordon I. Smith DCP, 2 Mihoko Yoshino,ET.AL. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics. J Clin Invest. 2020;130(6):3305-3314. Google Scholar
[5]
PhượngN. T. HT, HàL. T., HàH. T. V., PhươngN. M., Điều Đồng T. T., ThảoN. T., TrinhN. T. K., HuệT. T., ThảoB. X., & HảiN. T. Nghiên cứu tỷ lệ, đặc điểm người tiền đái tháo đường tại đơn vị Quân đội A trên địa bàn Hà Nội. Journal of 108 - Clinical Medicine and Phamarcy,. 2023;18(3) Google Scholar
[6]
Zhou Y, Zhang J, Liu RH, et al. Association between Health-Related Physical Fitness and Risk of Dyslipidemia in University Staff: A Cross-Sectional Study and a ROC Curve Analysis. Nutrients. Dec 23 2021;14(1)doi:10.3390/nu14010050 Google Scholar
[7]
Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. Bmj. Nov 23 2016;355:i5953. doi:10.1136/bmj.i5953 Google Scholar
[8]
Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. Jan 2016;126(1):12-22. doi:10.1172/jci77812 Google Scholar
[9]
ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. Jan 1 2023;46(Suppl 1):S19-s40. doi:10.2337/dc23-S002 Google Scholar
[10]
Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. May 2015;58(5):886-99. doi:10.1007/s00125-015-3525-8 Google Scholar
[11]
Trần TP, Trịnh PD, Trương VT, et al. Rối loạn lipid máu và một số yếu tố nguy cơ ở người bệnh đái tháo đường type 2 đang điều trị ngoại trú tại trung tâm y tế phủ lý. Tạp chí Y học Việt Nam. 12/20 2022;545(2)doi:10.51298/vmj.v545i2.12289 Google Scholar